The neuroprotective agent DP-b99 does not interact with s-warfarin in vivo despite significant CYP2C9 inhibition in vitro.

doi:10.1111/j.1742-7843.2010.00654.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The neuroprotective agent DP-b99 does not interact with s-warfarin in vivo despite significant CYP2C9 inhibition in vitro.

Basic & clinical pharmacology & toxicology - 1 Apr 2011

Rosenberg Gilad, Marshall Linda S, Caraco Yoseph

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Cross-Over Studies
Share to Cytochrome P-450 CYP2C9
Share to Double-Blind Method

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Egtazic Acid

Share to Neuroprotective Agents

Share to Warfarin

Source

Open in PubMed

Identifiers

PMID: 21414144
DOI: 10.1111/j.1742-7843.2010.00654.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The neuroprotective agent DP-b99 does not interact with s-warfarin in vivo despite significant CYP2C9 inhibition in vitro.PMID 21414144Read ↗

Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction.Semantic proximity Read ↗

Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.Semantic proximity Read ↗

Effects of clopidogrel on the pharmacokinetics of sibutramine and its active metabolites.Semantic proximity Read ↗

[Anticoagulation with warfarin].Semantic proximity Read ↗

[New clinical evidence and drugs].Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.Semantic proximity Read ↗

The clopidogrel conundrum.Semantic proximity Read ↗

The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discoverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.